Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1090

Bifidobacterium bifidum strain NITE BP-31

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants at a level of 2.28 x 106 colony forming units/mL.
Basis: Scientific procedures
Notifier: Meiji Co., Ltd.
Notifier Address: 1-29-1 Nanakuni, Hachiouji
Tokyo 192-0919
Japan
GRAS Notice (releasable information): GRN 1090 with amendments (in PDF) (9.2 MB)
Date of closure: Apr 5, 2023
FDA's Letter: FDA has no questions (in PDF) (209 kB)
-
-